Showing results (11-20 of 12,155) with videos related to
Sort By:
Pageof 1,216
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2004
Central structures necessary and sufficient for ingestive and glycemic responses to Urocortin I administrationDerek Daniels, Stacy Markison, Harvey J Grill, et al.Bioorganic & Medicinal Chemistry|June 5, 2007
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activityJoe A Tran, Fabio C Tucci, Wanlong Jiang, et al.Journal of Medicinal Chemistry|October 9, 2007
Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexiaChen Chen, Wanlong Jiang, Fabio Tucci, et al.Toxicology Reports|October 1, 2017
Toxicological evaluation of a novel cooling compound: 2-(4-methylphenoxy)-<i>N</i>-(1<i>H</i>-pyrazol-3-yl)-<i>N</i>-(2-thienylmethyl)acetamideDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.Toxicology Reports|October 1, 2017
Toxicological evaluation of the flavour ingredient 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acidAmy J Arthur, Donald S Karanewsky, Hanghui Liu, et al.Bioorganic & Medicinal Chemistry|April 18, 2008
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonistsChen Chen, Fabio C Tucci, Wanlong Jiang, et al.Journal of Medicinal Chemistry|November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptorJoe A Tran, Wanlong Jiang, Fabio C Tucci, et al.Optics Express|June 17, 2009
A family of approximations spanning the Born and Rytov scattering seriesDaniel L MarksToxicology Reports|September 30, 2017
Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)thio)methyl)pyridineDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.Toxicology Reports|September 30, 2017
Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dioneDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.Pageof 1,216